INA | Jotup

CIVITAS CAPITAL GROUP SUES USCIS FOR "ASTOUNDING" EB-5 FILING FEE INCREASE

Retrieved on:

Donnerstag, April 25, 2024

Congress, Immigration, Management, RIA, Administration, District court, USCIS, Regulatory Flexibility Act, INA, EB-5, Cryptocurrency

The lawsuit asks the court to set aside the EB-5 fee increases until USCIS has completed a required fee study and otherwise complied with applicable law.

Key Points:

The lawsuit asks the court to set aside the EB-5 fee increases until USCIS has completed a required fee study and otherwise complied with applicable law.
USCIS' rule increased fees for EB-5 filings across the board, failing to even distinguish between costs for large filings versus one-page forms.
We will prove this fee is egregious, but at least they're charging it for reviewing a substantive filing," Healy said.
Healy, a member of the IIUSA Board of Directors, says this unheard-of USCIS fee increase is unfair to investors, the backbone of the job-creating machine that is the EB-5 program.

FAIR: Senate Shirks Its Constitutional Duty on Impeachment to Hide Evidence from the American People

Retrieved on:

Mittwoch, April 17, 2024

Homeland security, Congress, Immigration, House, History, Senate, Federation, DHS, Representative, Public opinion, Multimedia, INA, FAIR, Security, Government

WASHINGTON, April 17, 2024 /PRNewswire/ -- "Today, the U.S. Senate took the unprecedented step of effectively dismissing the articles of impeachment against Homeland Security Secretary Alejandro Mayorkas that were passed by the House of Representatives. Never in the history of our republic has the Senate refused to carry out its constitutional obligation to adjudicate lawfully approved articles of impeachment against a government official.

Key Points:

Never in the history of our republic has the Senate refused to carry out its constitutional obligation to adjudicate lawfully approved articles of impeachment against a government official.
In fact, it is the Senate's summary effective dismissal of the articles of impeachment that was politically motivated.
"The articles of impeachment were based on a mountain of evidence, revealed through an extensive, months-long investigation, regarding Mayorkas' dereliction of duty as DHS secretary.
These charges were clearly sufficient to warrant a Senate trial to determine if Secretary Mayorkas should be removed from office.

A more competitive, self-sufficient and greener region: MOL Group is to achieve carbon neutrality with a smart transition

Retrieved on:

Donnerstag, März 14, 2024

Carbon, Community, Electricity, Carbon capture and storage, Consumer service, Geothermal energy, Waste management, Recycling, SHAPE, GHG, CEE, MOL, MOL (company), Exploration, European, INA, Renewable energy

MOL Group aims to achieve carbon neutrality by 2050 through smart transition: ensuring sustainability and further strengthening security of supply through innovative technologies.

Key Points:

MOL Group aims to achieve carbon neutrality by 2050 through smart transition: ensuring sustainability and further strengthening security of supply through innovative technologies.
MOL Group is ensuring a smart transition with tomorrow's solutions: investing in further strengthening the region's security of supply, creating value from waste and shaping the future of mobility with innovative technologies.
It will spend more than $4 billion on green investments by 2030 and aims to reach carbon neutrality by 2050.
To achieve these goals, we will increase the use of renewable electricity across the MOL Group, particularly in the Downstream area.

AEON Biopharma Presents Positive Clinical and Pre-clinical Data for ABP-450 (prabotulinumtoxinA) in Treating Cervical Dystonia and PTSD, Respectively, at a Leading Neurotoxin Conference

Retrieved on:

Donnerstag, Januar 18, 2024

IRVINE, Calif., Jan. 18, 2024 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON, AEON WS), a clinical-stage biopharmaceutical company focused on developing a proprietary botulinum toxin complex for the treatment of multiple debilitating medical conditions, today presented new clinical and pre-clinical data for ABP-450 in treating cervical dystonia (CD) and posttraumatic stress disorder (PTSD) at TOXINS 2024, a leading conference held by the International Neurotoxin Association (INA) from January 17th - 20th at the Estrel Berlin in Berlin, Germany.

Key Points:

ABP-450 did not appear to increase treatment-related TEAEs at any dose in the study.
These results support further investigation of ABP-450 as a treatment option for patients with CD and other movement disorders.
“We are excited to announce positive data from the 52-week OLE portion of the Phase 2 study of ABP-450 for CD.
The posters presented by AEON at the TOXINS 2024 conference can be accessed on the Events and Presentations page of the Company’s corporate website.

With INA, Sopra Steria and Telefónica are propelling the telecommunications industry into the quantum era and revolutionising network management

Retrieved on:

Freitag, November 17, 2023

Sopra Steria, INA, Mobile phone

PARIS, Nov. 17, 2023 /PRNewswire/ -- Sopra Steria, a major player in the European tech sector, working closely with Telefónica, is revolutionising network management and planning with the launch of the Intelligent Network Analyzer (INA).

Key Points:

PARIS, Nov. 17, 2023 /PRNewswire/ -- Sopra Steria, a major player in the European tech sector, working closely with Telefónica, is revolutionising network management and planning with the launch of the Intelligent Network Analyzer (INA).
Leveraging the Azure Quantum solution, Sopra Steria and Telefónica are harnessing the latest breakthroughs in quantum technology to optimise telecoms networks in Germany, showing how they can boost their technological performance while becoming more energy-efficient and sustainable.
This quantum simulation, which was successfully carried out with Telefónica's mobile network data, combines real-time mapping and dynamic traffic management within a single system.
Sven Wißmann (Global Industry Lead Telecommunications) at Sopra Steria, commented: "The INA project is more than just a breakthrough in mobile network analysis.

With INA, Sopra Steria and Telefónica are propelling the telecommunications industry into the quantum era and revolutionising network management

Retrieved on:

Freitag, November 17, 2023

Sopra Steria, INA, Mobile phone

PARIS, Nov. 17, 2023 /PRNewswire/ -- Sopra Steria, a major player in the European tech sector, working closely with Telefónica, is revolutionising network management and planning with the launch of the Intelligent Network Analyzer (INA).

Key Points:

PARIS, Nov. 17, 2023 /PRNewswire/ -- Sopra Steria, a major player in the European tech sector, working closely with Telefónica, is revolutionising network management and planning with the launch of the Intelligent Network Analyzer (INA).
Leveraging the Azure Quantum solution, Sopra Steria and Telefónica are harnessing the latest breakthroughs in quantum technology to optimise telecoms networks in Germany, showing how they can boost their technological performance while becoming more energy-efficient and sustainable.
This quantum simulation, which was successfully carried out with Telefónica's mobile network data, combines real-time mapping and dynamic traffic management within a single system.
Sven Wißmann (Global Industry Lead Telecommunications) at Sopra Steria, commented: "The INA project is more than just a breakthrough in mobile network analysis.

INFINITT North America (INA) is excited to share the news of its latest collaboration with Aiforia

Retrieved on:

Mittwoch, November 8, 2023

IDPS, Ageing, HIMSS, Marie Cassidy, Prevalence, Pathology, News, Accreditation, Lung, Neuroscience, Cancer, AI, Breast, Patient, Prostate, Medical imaging, INA

PHILLIPSBURG, N.J., Nov. 8, 2023 /PRNewswire/ -- INFINITT North America (INA) is excited to share the news of its latest collaboration with Aiforia.

Key Points:

INA's digital pathology solution, IDPS, enables seamless integration of whole-slide images from various scanner vendors into existing workflows.
The collaboration also intends to integrate Aiforia's Clinical Suites with INA's solutions for diagnosing common cancers.
PHILLIPSBURG, N.J., Nov. 8, 2023 /PRNewswire/ -- INFINITT North America (INA) is excited to share the news of its latest collaboration with Aiforia.
INFINITT, a renowned developer of enterprise imaging solutions worldwide, eagerly anticipates common go-to-market initiatives with Aiforia and incorporating Aiforia's expertise into their INFINITT Digital Pathology Solution (IDPS).

INVT.AI Brings AI Consulting On-Chain

Retrieved on:

Freitag, Oktober 27, 2023

Sale, Ethereum, Data, DAO, Telegraphy, Data analysis, Machine learning, Marketing, Ecosystem, Algorithm, Discord, AI, INA, Cryptocurrency, Sales

One of the company’s core strengths is its Invt.AI Bot and Agent.

Key Points:

One of the company’s core strengths is its Invt.AI Bot and Agent.
Additionally, INA tokens will embody governance power, allowing token holders to actively participate in key decision-making processes, shaping the future trajectory of the platform.
With the seamless integration of INA tokens, Invt.AI aims to foster a vibrant and engaged community, driving the next wave of innovation in the AI space, backed by the secure and efficient InvtAI blockchain node.
It is also a prerequisite to enrolling in the referral program, which will let participants receive a 6.9% bonus coming from their referees’ contributions.

SUN COMMUNITIES, INC. ANNOUNCES PLANNED DISPOSITION OF STAKE IN INGENIA

Retrieved on:

Donnerstag, Oktober 12, 2023

Partnership, RV, NYSE, Australian Securities Exchange, MH, SUI, Sun Communities, INA, Trust, Sale, Housing, Automotive industry, Ingenia

The sale is anticipated to generate a minimum net proceeds of US$100 million.

Key Points:

The sale is anticipated to generate a minimum net proceeds of US$100 million.
In 2018, the Company entered a joint venture partnership with, and concurrently subscribed for a stake in, Ingenia, a leading owner, operator and developer of senior manufactured housing communities and holiday resorts in Australia.
In August 2023, the Company agreed terms to extend its joint venture partnership with Ingenia for a further seven years.
Separate from the Sungenia joint venture, the Company has decided to dispose of its direct holdings in Ingenia shares and to use the net proceeds to pay down debt.

INFINITT North America Facilitates Cardiology Solution Collaboration Between Marlette Regional Hospital and Deckerville Community Hospital

Retrieved on:

Freitag, September 1, 2023

PHILLIPSBURG, N.J., Sept. 1, 2023 /PRNewswire-PRWeb/ -- For over 70 years, Deckerville Community Hospital has been dedicated to serving its community and has held the distinction of being a certified Critical Access Hospital for the past 22 years. The hospital provides a variety of patient services such as laboratory work, inpatient care, medical imaging, and more. In the autumn of 2018, an official partnership began between Marlette Regional Hospital and Deckerville Community Hospital, which is overseen by United Healthcare Partners—a parent corporation. This alliance aims to accomplish three main objectives: reduce costs by minimizing duplicated services and leveraging market presence for better pricing; maintain and expand healthcare services; and retain local control over healthcare management.

Key Points:

In the autumn of 2018, an official partnership began between Marlette Regional Hospital and Deckerville Community Hospital, which is overseen by United Healthcare Partners—a parent corporation.
Katrina Pandrea Moorehead, Director of Ancillary Services and Cardiopulmonary Manager at Marlette Regional Hospital adds, "Thanks to the exceptional team at INFINITT North America and Deckerville Community Hospital for working together collaboratively with Marlette Regional Hospital to bring Cardiac Echo images from Deckerville Hospital to Marlette Hospital's CPACS for interpretation.
INFINITT North America (INA) operates in 56 countries, on five continents: with over 6500 installations and counting.
INFINITT has been ranked Best-in-KLAS Category Leader for the Community Hospital market and Imaging Center/Ambulatory market over 12 times.